@article{CDT4976,
author = {Béatrice Bonello and Sébastien Renard and Julien Mancini and Sandrine Huber and Gilbert Habib and Alain Fraisse},
title = {Life span of patients with Eisenmenger syndrome is not superior to that of patients with other causes of pulmonary hypertension},
journal = {Cardiovascular Diagnosis and Therapy},
volume = {4},
number = {5},
year = {2014},
keywords = {},
abstract = {Background: Patients with Eisenmenger syndrome (ES) carry a better prognosis from diagnosis than patients with other causes of pulmonary hypertension (PH), but their life span has not yet been clarified.
Aims: To clarify both survival from diagnosis and life span in ES, and in closed shunt with pulmonary arterial hypertension (PAH), as compared with other causes of PH.
Methods: Data on all adult patients with PH attending our centre over the past decade was collected. Outcome was defined as death or transplantation.
Results: We studied 149 patients, including 30 (20%) patients with ES and 12 (8%) patients with closed shunt with PAH. Median age at diagnosis was lower for patients with ES and closed-shunt with PAH compared to patients with other causes of PH (P},
issn = {2223-3660}, url = {https://cdt.amegroups.org/article/view/4976}
}